| N (%) | t | SSig. (2-tailed) | Std. Error | 95% CI | |||
---|---|---|---|---|---|---|---|---|
Lower | Upper | |||||||
SPAG5 | Age | < 50 years | 16(40) | − 1.05 | 0.29 | 1.19 | − 3.67 | 1.15 |
> 50 years | 24(60) | |||||||
Grade | I and II | 30(75) | − 0.97 | 0.33 | 1.31 | − 3.94 | 1.37 | |
III | 10(25) | |||||||
LN | Positive | 18(45.5) | 0.77 | 0.44 | 1.18 | − 1.47 | 3.31 | |
Negative | 22(55.5 | |||||||
FH | Positive | 13(32.5) | 0.78 | 0.43 | 1.25 | − 1.55 | 3.53 | |
Negative | 27(67.5) | |||||||
ER | Positive | 35(87.5) | − 0.19 | 0.84 | 1.79 | − 3.98 | 3.27 | |
Negative | 5(12.5) | |||||||
PR | Positive | 33(82.5) | − 0.02 | 0.98 | 1.56 | − 3.20 | 3.12 | |
Negative | 7(17.5) | |||||||
HER2 | Positive | 7(17.5) | − 0.02 | 0.98 | 1.56 | − 3.20 | 3.12 | |
Negative | 33(82.5) | |||||||
NUMA | Age | < 50 years | 16(40) | 0.89 | 0.37 | 0.79 | − 0.90 | 2.32 |
> 50 years | 24(60) | |||||||
Grade | I and II | 30(75) | − 1.91 | 0.06 | 0.84 | − 3.32 | 0.09 | |
III | 10(25) | |||||||
LN | Positive | 18(45.5) | − 1.0 | 0.32 | 0.78 | − 2.37 | 0.79 | |
Negative | 22(55.5 | |||||||
FH | Positive | 13(32.5) | − 1.93 | 0.06 | 0.80 | − 3.18 | 0.06 | |
Negative | 27(67.5) | |||||||
ER | Positive | 35(87.5) | − 2.90 | 0.006 | 1.07 | − 5.32 | − 0.95 | |
Negative | 5(12.5) | |||||||
PR | Positive | 33(82.5) | − 0.79 | 0.43 | 1.03 | − 2.90 | 1.26 | |
Negative | 7(17.5) | |||||||
HER2 | Positive | 7(17.5) | − 0.79 | 0.43 | 1.03 | − 2.90 | 1.26 | |
Negative | 33(82.5) |